Eckert & Ziegler Past Earnings Performance

Past criteria checks 4/6

Eckert & Ziegler has been growing earnings at an average annual rate of 9.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 10.3% per year. Eckert & Ziegler's return on equity is 14.7%, and it has net margins of 12.9%.

Key information

9.6%

Earnings growth rate

9.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate10.3%
Return on equity14.7%
Net Margin12.9%
Next Earnings Update27 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Eckert & Ziegler makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:EUZ Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2427836690
30 Jun 2427438690
31 Mar 2425634660
31 Dec 2324630640
30 Sep 2324033600
30 Jun 2323329590
31 Mar 2323030590
31 Dec 2222231580
30 Sep 2221527610
30 Jun 2219827580
31 Mar 2218627560
31 Dec 2118035540
30 Sep 2118033570
30 Jun 2118231540
31 Mar 2117630520
31 Dec 2017621510
30 Sep 2017221480
30 Jun 2017322500
31 Mar 2017921510
31 Dec 1917822510
30 Sep 1917822520
30 Jun 1917721530
31 Mar 1917720520
31 Dec 1816916500
30 Sep 1816216470
30 Jun 1815514450
31 Mar 1814211440
31 Dec 1713912440
30 Sep 1713111430
30 Jun 1712411440
31 Mar 1711711410
31 Dec 1612010430
30 Sep 161279460
30 Jun 161329470
31 Mar 1614211510
31 Dec 1514012520
30 Sep 1513711510
30 Jun 1513412510
31 Mar 151308490
31 Dec 141277480
30 Sep 14124847-3
30 Jun 14124846-2
31 Mar 14121946-1
31 Dec 131179440

Quality Earnings: EUZ has high quality earnings.

Growing Profit Margin: EUZ's current net profit margins (12.9%) are lower than last year (13.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EUZ's earnings have grown by 9.6% per year over the past 5 years.

Accelerating Growth: EUZ's earnings growth over the past year (10.1%) exceeds its 5-year average (9.6% per year).

Earnings vs Industry: EUZ earnings growth over the past year (10.1%) exceeded the Medical Equipment industry 10.1%.


Return on Equity

High ROE: EUZ's Return on Equity (14.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 12:27
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eckert & Ziegler SE is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adrian KowollikDr. Kalliwoda Research
Alexander GalitsaHauck Aufhäuser Investment Banking
Simon KellerHauck Aufhäuser Investment Banking